Clinical trial
Bioequivalence And Lack Of Food Effects Of 300mg Lamotrigine XR
NCT00412191 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00412191 |
|---|---|
| Title | Bioequivalence And Lack Of Food Effects Of 300mg Lamotrigine XR |
| Official title | A Pivotal Single-dose Randomised, Parallel-group, Open-label Study to Demonstrate Bioequivalence of 300mg Lamotrigine XR Relative to 100mg + 200mg Lamotrigine XR and to Demonstrate Lack of Food Effect on 300mg Lamotrigine XR in Healthy Male and Female Volunteers |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Epilepsy |
| Intervention type | Drug |
| Interventions | Lamotrigine |
| Enrollment | 180 |
| Start date | Feb 6, 2007 |
| Primary completion | Apr 27, 2007 |
| Completion | Apr 27, 2007 |
| First posted | Dec 15, 2006 |
| Last update posted | Aug 7, 2017 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: